Funded Tech Companies

ImmuneXcite

Wondering who invested in ImmuneXcite? Private investors, Sanofi-Genzyme BioVentures and Partners Innovation Fund put venture money into this biopharmaceutical company.

Company Overview

Company Name
ImmuneXcite
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
3 Forbes Rd.
Lexington, MA 02421
USA
Email Address

Company Background Information

Overview
The mAbXcite platform is ImmuneXcite's proprietary product-focused drug discovery engine that represents a fundamentally new approach in the rapidly growing field of cancer immunotherapy.
Profile
ImmuneXcite LinkedIn Company Profile
Social Media
ImmuneXcite Company Twitter Account
Company News
ImmuneXcite News
Facebook
ImmuneXcite on Facebook
YouTube
ImmuneXcite on YouTube
Last Transaction
2/2/2017

Financing History

Date
Type
Amount
Debt
$2,672,359
Venture Equity
$8,600,100
Venture Equity
$8,600,000
Venture Equity
$3,579,950
Venture Equity
$2,418,788


Management Team

Title
Name
Email & Social
Chief Executive Officer
Eric Furfine
  Eric Furfine LinkedIn Profile  Eric Furfine Twitter Account  Eric Furfine News  Eric Furfine on Facebook
Chief Scientific Officer
Ifat Rubin-Bejerano
  Ifat Rubin-Bejerano LinkedIn Profile  Ifat Rubin-Bejerano Twitter Account  Ifat Rubin-Bejerano News  Ifat Rubin-Bejerano on Facebook


Company Investors

  • Sanofi-Genzyme BioVentures (ann DeWitt)
  • Partners Innovation Fund
  • Cormorant Asset Management

 

 

 

Browse more funded tech companies:

ImmuneWorks | ImmunGene

 

Share this article

 


About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary